Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Pedersen

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|January 30, 1997
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study GroupM Johannesson, B Jönsson, J Kjekshus, et al.
European Heart Journal|November 20, 1998
Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S)O Faergeman, J Kjekshus, T Cook, et al.
Annals of the Rheumatic Diseases|April 5, 2014
Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular preventionS Rollefstad, E Ikdahl, J Hisdal, et al.
Clinical Therapeutics|September 6, 2000
Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients studyT R Pedersen, K E Jahnsen, S Vatn, et al.
Circulation|December 19, 2001
Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4SC M Ballantyne, A G Olsson, T J Cook, et al.
Annals of the Rheumatic Diseases|June 17, 2010
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) StudyA G Semb, T K Kvien, A H Aastveit, et al.
Physical Review Letters|May 21, 2005
Ionospheric modification at twice the electron cyclotron frequencyF T Djuth, T R Pedersen, E A Gerken, et al.
The American Journal of Cardiology|February 19, 1998
Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)T R Pedersen, J Kjekshus, K Pyörälä, et al.
Archives of Internal Medicine|December 22, 1999
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival StudyS M Haffner, C M Alexander, T J Cook, et al.
Diabetes Care|November 5, 1999
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival StudyW H Herman, C M Alexander, J R Cook, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|January 30, 1997
Cost effectiveness of simvastatin treatment to lower cholesterol levels in patients with coronary heart disease. Scandinavian Simvastatin Survival Study GroupM Johannesson, B Jönsson, J Kjekshus, et al.
European Heart Journal|November 20, 1998
Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S)O Faergeman, J Kjekshus, T Cook, et al.
Annals of the Rheumatic Diseases|April 5, 2014
Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular preventionS Rollefstad, E Ikdahl, J Hisdal, et al.
Clinical Therapeutics|September 6, 2000
Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients studyT R Pedersen, K E Jahnsen, S Vatn, et al.
Circulation|December 19, 2001
Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4SC M Ballantyne, A G Olsson, T J Cook, et al.
Annals of the Rheumatic Diseases|June 17, 2010
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) StudyA G Semb, T K Kvien, A H Aastveit, et al.
Physical Review Letters|May 21, 2005
Ionospheric modification at twice the electron cyclotron frequencyF T Djuth, T R Pedersen, E A Gerken, et al.
The American Journal of Cardiology|February 19, 1998
Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)T R Pedersen, J Kjekshus, K Pyörälä, et al.
Archives of Internal Medicine|December 22, 1999
Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival StudyS M Haffner, C M Alexander, T J Cook, et al.
Diabetes Care|November 5, 1999
Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival StudyW H Herman, C M Alexander, J R Cook, et al.
Pageof 5